FDA label f25c5652-804c-44e4-949c-058e5f073ef9

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID: cf0f5203-bc80-4715-9fda-2819f856dd0b
SPL ID: f25c5652-804c-44e4-949c-058e5f073ef9
Version: 5
Effective date: 2013-08-23
Source export date: 2026-10-12
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b8dac220ac9fc8ffb4d86c6e00ece30169fc4575ca0cc92e5c9ce1a524fb0249/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 03:01:16

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 2 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
spl id		f25c5652-804c-44e4-949c-058e5f073ef9	id
spl set id		cf0f5203-bc80-4715-9fda-2819f856dd0b	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: The effect of Chlorhexidine Gluconate Oral Rinse on perodontitis has not been determined. An increase in supragingivitis was not noted in clinical testing in chlorhexidine gluconate oral rinse users compared with control users. It is not known if chlorhexidine gluconate oral rinse use results in an increase of subgingival calculus. Calculus deposits should be removed by dental prophylaxis at intervals not greater than six months. Hypersensitivity and generalized allergic reactions have occured. Read CONTRAINDICATIONS indicated on the insert inside the box.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.